Application no. and date | 12183760.3 (espacenet) (Federated) (European Patent Register), 20080918 | Patent/reg. no. and date | DK/EP 2535716, 20161102 | Publication date | 20121219 | Priority no. and date | GB 0718167, 20070918 | EP pub. no. and date |
EP 2535716 20121219 | Effective date | | Applicant/owner | Cancer Research Technology Limited, Angel Building 407 St John Street London EC1V 4AD, GB | Applicant ref. no. | P53318DK03 | Inventor | Slettenaar, Violet, c/o Institute of Cancer Queen Mary University of London Charterhouse Square
London EC1M 6BQ, GB, Wilson, Julia, c/o Institute of Cancer Queen Mary University of London Charterhouse Square
London EC1M 6BQ, GB, Wang, Yaohe, c/o Institute of Cancer Queen Mary University of London Charterhouse Square
London EC1M 6BQ, GB, Schioppa, Tiziana, c/o Institute of Cancer Queen Mary University of London Charterhouse Square
London EC1M 6BQ, GB, Balkwill, Frances, c/o Institute of Cancer Queen Mary University of London Charterhouse Square
London EC1M 6BQ, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/00 (2006.01) , G01N 33/50 (2006.01) , G01N 33/574 (2006.01) | Title | Cancermarkør og terapeutisk mål | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|